• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

采用混合式深静脉动脉化技术对无法进行血管重建的慢性肢体威胁性缺血患者进行为期5年的保肢治疗以实现长期肢体挽救:一例病例报告

A 5-year limb salvage for long-term limb salvage in chronic limb-threatening ischemia without options for revascularization, utilizing a hybrid deep venous arterialization technique: A case report.

作者信息

Ferrer Lucas, Malin Lynsey, Koutakis Panagiotis, Miserlis Dimitrios

机构信息

Vascular and Endovascular Surgery, University of Texas at Austin Dell Medical School, Austin, TX, USA.

Department of Public Health, College of Health, University of West Florida, Pensacola, FL, USA.

出版信息

Sci Prog. 2025 Apr-Jun;108(2):368504251352033. doi: 10.1177/00368504251352033. Epub 2025 Jun 25.

DOI:10.1177/00368504251352033
PMID:40566874
Abstract

Chronic limb-threatening ischemia represents the most severe form of peripheral arterial disease, with a 40% amputation rate and 20% mortality at 6 months without revascularization. Deep venous arterialization is an alternative for patients with advanced peripheral arterial disease who have no conventional revascularization surgery option based on their anatomy-no distal artery target to redirect arterial blood. Hybrid deep venous arterialization, which combines open surgical bypass with venous endovascular arterialization and valvulotomy, is a technique under investigation for limb salvage with limited current long-term data. We present a successful limb salvage case report of an early 60s male with no conventional revascularization options who presented with a wound in his foot and underwent a successful hybrid deep venous arterialization. The hybrid deep venous arterialization technique has shown promising preliminary results for long-term limb salvage at 5 years after surgery. This case report establishes a tangible example of the potential role of hybrid deep venous arterialization in the management of patients with no-option chronic limb-threatening ischemia. After a 5-year follow-up, the reported patient has no ischemic symptoms, and he is able to ambulate without support.

摘要

慢性肢体威胁性缺血是外周动脉疾病最严重的形式,在未经血运重建的情况下,6个月时截肢率为40%,死亡率为20%。对于因解剖结构原因没有传统血运重建手术选择(即没有可重定向动脉血的远端动脉靶点)的晚期外周动脉疾病患者,深静脉动脉化是一种替代方案。混合式深静脉动脉化将开放手术旁路与静脉腔内动脉化及瓣膜切开术相结合,是一种正在研究的用于肢体挽救的技术,目前长期数据有限。我们报告一例成功的肢体挽救病例,患者为一名60岁出头男性,没有传统血运重建选择,足部有伤口,接受了成功的混合式深静脉动脉化手术。混合式深静脉动脉化技术在术后5年的长期肢体挽救方面已显示出有前景的初步结果。本病例报告为混合式深静脉动脉化在无可选择的慢性肢体威胁性缺血患者管理中的潜在作用树立了一个切实的范例。经过5年随访,该报告患者没有缺血症状,能够在无支撑的情况下行走。

相似文献

1
A 5-year limb salvage for long-term limb salvage in chronic limb-threatening ischemia without options for revascularization, utilizing a hybrid deep venous arterialization technique: A case report.采用混合式深静脉动脉化技术对无法进行血管重建的慢性肢体威胁性缺血患者进行为期5年的保肢治疗以实现长期肢体挽救:一例病例报告
Sci Prog. 2025 Apr-Jun;108(2):368504251352033. doi: 10.1177/00368504251352033. Epub 2025 Jun 25.
2
Transcatheter Arterialization of Deep Veins in Chronic Limb-Threatening Ischemia.经导管动脉化治疗慢性肢体缺血性疾病的深部静脉
N Engl J Med. 2023 Mar 30;388(13):1171-1180. doi: 10.1056/NEJMoa2212754.
3
Female patients have fewer limb amputations compared to male patients in the BEST-CLI trial.在BEST-CLI试验中,女性患者的肢体截肢情况比男性患者少。
J Vasc Surg. 2025 Feb;81(2):366-373.e1. doi: 10.1016/j.jvs.2024.09.031. Epub 2024 Oct 4.
4
Association of Lipoprotein(a) With Major Adverse Limb Events and All-Cause Mortality Following Revascularization for Chronic Limb-Threatening Ischemia: A Substudy of the BEST-CLI Trial.脂蛋白(a)与慢性肢体威胁性缺血血运重建术后主要不良肢体事件及全因死亡率的关联:BEST-CLI试验的一项子研究
J Am Heart Assoc. 2025 Jun 3;14(11):e041177. doi: 10.1161/JAHA.125.041177. Epub 2025 May 22.
5
Open, percutaneous, and hybrid deep venous arterialization technique for no-option foot salvage.开放式、经皮和杂交深静脉动脉化技术用于无选择的足部挽救。
J Vasc Surg. 2020 Jun;71(6):2152-2160. doi: 10.1016/j.jvs.2019.10.085. Epub 2019 Dec 31.
6
Outcomes of chronic limb-threatening ischemia revascularization in patients with chronic kidney disease in the BEST-CLI trial.BEST-CLI试验中慢性肾脏病患者慢性肢体威胁性缺血血运重建的结果
J Vasc Surg. 2025 Apr;81(4):945-956.e3. doi: 10.1016/j.jvs.2024.12.128. Epub 2025 Jan 23.
7
Interposition vein cuff for infragenicular prosthetic bypass graft.用于膝下人工血管搭桥移植的间置静脉袖套
Cochrane Database Syst Rev. 2012 Sep 12;2012(9):CD007921. doi: 10.1002/14651858.CD007921.pub2.
8
Age-Related Outcomes After Revascularization for Chronic Limb-Threatening Ischemia: An Analysis of BEST-CLI.慢性肢体威胁性缺血血管重建术后的年龄相关结局:BEST-CLI分析
Circ Cardiovasc Interv. 2025 Jun;18(6):e014833. doi: 10.1161/CIRCINTERVENTIONS.124.014833. Epub 2025 Apr 3.
9
Lumbar sympathectomy versus prostanoids for critical limb ischaemia due to non-reconstructable peripheral arterial disease.腰交感神经切除术与前列腺素类药物治疗因不可重建的外周动脉疾病导致的严重肢体缺血的比较
Cochrane Database Syst Rev. 2018 Apr 16;4(4):CD009366. doi: 10.1002/14651858.CD009366.pub2.
10
A vein bypass first versus a best endovascular treatment first revascularization strategy for patients with chronic limb-threatening ischaemia who require an infra-popliteal, with or without an additional more proximal infra-inguinal, revascularization procedure to restore limb perfusion: the BASIL-2 within-trial health economic analysis.对于需要进行腘下(无论是否伴有额外的更靠近侧的腹股沟下)血管重建手术以恢复肢体灌注的慢性肢体威胁性缺血患者,采用先进行静脉搭桥术与先进行最佳血管内治疗的血管重建策略对比:BASIL-2试验内健康经济分析
Br J Surg. 2025 May 31;112(6). doi: 10.1093/bjs/znaf119.

本文引用的文献

1
Transcatheter Arterialization of Deep Veins in Chronic Limb-Threatening Ischemia.经导管动脉化治疗慢性肢体缺血性疾病的深部静脉
N Engl J Med. 2023 Mar 30;388(13):1171-1180. doi: 10.1056/NEJMoa2212754.
2
Open, percutaneous, and hybrid deep venous arterialization technique for no-option foot salvage.开放式、经皮和杂交深静脉动脉化技术用于无选择的足部挽救。
J Vasc Surg. 2020 Jun;71(6):2152-2160. doi: 10.1016/j.jvs.2019.10.085. Epub 2019 Dec 31.
3
PLX-PAD Cell Treatment of Critical Limb Ischaemia: Rationale and Design of the PACE Trial.
PLX-PAD 细胞治疗严重肢体缺血:PACE 试验的原理和设计。
Eur J Vasc Endovasc Surg. 2019 Apr;57(4):538-545. doi: 10.1016/j.ejvs.2018.11.008. Epub 2019 Jan 25.
4
Hybrid Foot Vein Arterialization in No-Option Patients With Critical Limb Ischemia: A Preliminary Report.杂交足静脉动脉化治疗无选择肢端缺血患者:初步报告。
J Endovasc Ther. 2019 Feb;26(1):7-17. doi: 10.1177/1526602818820792. Epub 2018 Dec 28.
5
BAD transmission and SAD distribution: a new scenario for critical limb ischemia.BAD传输与SAD分布:严重肢体缺血的新情况。
J Cardiovasc Surg (Torino). 2018 Oct;59(5):655-664. doi: 10.23736/S0021-9509.18.10572-6. Epub 2018 May 22.
6
The natural history of untreated severe or critical limb ischemia.未经治疗的严重或危急肢体缺血的自然病程。
J Vasc Surg. 2015 Dec;62(6):1642-51.e3. doi: 10.1016/j.jvs.2015.07.065. Epub 2015 Sep 26.
7
Surgical intervention for peripheral arterial disease.外周动脉疾病的手术干预。
Circ Res. 2015 Apr 24;116(9):1614-28. doi: 10.1161/CIRCRESAHA.116.303504.
8
Overview of classification systems in peripheral artery disease.外周动脉疾病分类系统概述。
Semin Intervent Radiol. 2014 Dec;31(4):378-88. doi: 10.1055/s-0034-1393976.
9
Oxidative damage in the gastrocnemius of patients with peripheral artery disease is myofiber type selective.周围血管疾病患者腓肠肌的氧化损伤具有肌纤维类型选择性。
Redox Biol. 2014 Jul 19;2:921-8. doi: 10.1016/j.redox.2014.07.002. eCollection 2014.
10
The CARE guidelines: consensus-based clinical case reporting guideline development.CARE 指南:基于共识的临床病例报告指南制定。
Headache. 2013 Nov-Dec;53(10):1541-7. doi: 10.1111/head.12246.